Rat liver peroxisomes after fibrate treatment. A survey using quantitative mass spectrometry.
Fibrates are known to induce peroxisome proliferation and the expression of peroxisomal beta-oxidation enzymes. To analyze fibrate-induced changes of complex metabolic networks, we have compared the proteome of rat liver peroxisomes from control and bezafibrate-treated rats. Highly purified peroxisomes were subfractionated, and the proteins of the matrix, peripheral, and integral membrane subfractions thus obtained were analyzed by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry after labeling of tryptic peptides with the iTRAQ reagent. By means of this quantitative technique, we were able to identify 134 individual proteins, covering most of the known peroxisomal proteome. Ten predicted new open reading frames were verified by cDNA cloning, and seven of them could be localized to peroxisomes by immunocytochemistry. Moreover, quantitative mass spectrometry substantiated the induction of most of the known peroxisome proliferator-activated receptor alpha-regulated peroxisomal proteins upon treatment with bezafibrate, documenting the suitability of the iTRAQ procedure in larger scale experiments. However, not all proteins reacted to a similar extent but exerted a fibrate-specific induction scheme showing the variability of peroxisome proliferator-activated receptoralpha-transmitted responses to specific ligands. In view of our data, rat hepatic peroxisomes are apparently not specialized to sequester very long chain fatty acids (C22-C26) but rather metabolize preferentially long chain fatty acids (C16-18).
Islinger
Markus
M
Department of Anatomy and Cell Biology, Ruprecht-Karl University, 69120 Heidelberg, Germany. Markus.Islinger@urz.uni-heidelberg.de
Lüers
Georg H
GH
Li
Ka Wan
KW
Loos
Maarten
M
Völkl
Alfred
A
D000818:Animals; D001629:Bezafibrate / Q000494:pharmacology; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D005260:Female; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D013058:Mass Spectrometry / Q000379:methods*; D010100:Oxygen / Q000378:metabolism; D047493:PPAR alpha / Q000378:metabolism; D020675:Peroxisomes / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013347:Subcellular Fractions
D000960:Hypolipidemic Agents; D047493:PPAR alpha; D010100:Oxygen; D001629:Bezafibrate